EquityBulls

Latest News

Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
CSM Technologies Posts Robust FY26 Results: Full-Year Net Profit Surges 70.2% to ₹24.01 Crore; Board Recommends Final Dividend
Nifty Slips Nearly 100 Points; Broader Market Outperforms
RITES & MECON sign MoU to explore business avenues
California Software Company Q1 FY27 Results: Consolidated Net Profit Surges 2,071% YoY to ₹4.19 Crore; Revenue Up 329%

Keywords Selected: Tablets

Stock Report

Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
Lupin Launches Azilsartan Medoxomil Tablets in the United States
Dr. Reddy's announces the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif®, in the United States
Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
Lupin Launches Dapagliflozin Tablets in the United States
Lupin announces approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma Ltd receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Aurobindo Pharma receives USFDA Approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
Lupin Announces the Approval of Dapagliflozin Tablets in the United States
Aurobindo Pharma receives USFDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg
Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
Eugia Pharma receives USFDA Approval for Everolimus Tablets
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg